Objectives: rh-IFNα2a-NGR is a promising anti-tumor candidate. The aim of present study was to compare pharmacokinetics of rh-IFNα2a-NGR with rh-IFNα2a.
Methods: Pharmacokinetics and elimination were investigated after intravenous administration to mice and rats.